Scientists have identified the Camp Hill virus, a henipavirus, in shrews in Alabama, marking its first detection in North ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it ...

The global CTNG testing market is anticipated to reach a valuation of USD 1.8 Billion in 2024, driven by focus on scalability and flexibility. The trend is expected to create new opportunities for the ...

Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a ...

Surface-enhanced Raman spectroscopy (SERS) is revolutionizing biomedical diagnostics and therapeutics, enabling breakthroughs ...

Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company, announced on Monday, that it has regained compliance with Nasdaq's ...

Cancer is a leading cause of death worldwide but several ASX biotechs are focused on early detection and treatment to improve ...

Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information About Mainz Biomed NV Mainz Biomed develops market-ready molecular genetic diagnostic ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have ...